| scholarly article | Q13442814 |
| P50 | author | Iris Y Navarro-Millán | Q56490865 |
| Jeffrey R Curtis | Q87706464 | ||
| Monika M Safford | Q88413396 | ||
| Ted R Mikuls | Q90157913 | ||
| Grant W Cannon | Q91431519 | ||
| Elizabeth Delzell | Q114560702 | ||
| Jasvinder Singh | Q50285669 | ||
| P2093 | author name string | Jie Zhang | |
| Shuo Yang | |||
| Lang Chen | |||
| Scott L DuVall | |||
| Nivedita M Patkar | |||
| John Baddley | |||
| P2860 | cites work | Baseline levels of c-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis : A ten-year followup study of a primary care-based inception cohort | Q57804967 |
| Seronegative rheumatoid arthritis in elderly and polymyalgia rheumatica have similar patterns of HLA association | Q73483655 | ||
| Recent improvements in survival in patients with rheumatoid arthritis: better outcomes or different study designs? | Q74024202 | ||
| High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors | Q77406810 | ||
| Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis | Q81412936 | ||
| CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study | Q28268514 | ||
| Validating administrative data in stroke research | Q30736500 | ||
| Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data | Q31135274 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| Autoantibodies and the risk of cardiovascular events | Q33721605 | ||
| Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source | Q34017348 | ||
| Interaction analysis between HLA-DRB1 shared epitope alleles and MHC class II transactivator CIITA gene with regard to risk of rheumatoid arthritis | Q34213779 | ||
| Validation of acute myocardial infarction in the Food and Drug Administration's Mini-Sentinel program | Q34320788 | ||
| Association of the HLA-DRB1 gene with premature death, particularly from cardiovascular disease, in patients with rheumatoid arthritis and inflammatory polyarthritis | Q34401259 | ||
| Lipid paradox in rheumatoid arthritis: the impact of serum lipid measures and systemic inflammation on the risk of cardiovascular disease | Q34684331 | ||
| Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis | Q35036976 | ||
| Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 | ||
| Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records | Q35816364 | ||
| High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis | Q36183213 | ||
| Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates | Q36661519 | ||
| Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. | Q36738148 | ||
| Effect of rheumatoid factor on mortality and coronary heart disease | Q36843049 | ||
| Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. | Q36901936 | ||
| The influence of age at symptom onset and length of followup on mortality in patients with recent-onset inflammatory polyarthritis | Q37173846 | ||
| Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. | Q37583248 | ||
| Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm | Q38115132 | ||
| The widening mortality gap between rheumatoid arthritis patients and the general population | Q38459919 | ||
| Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial | Q38473723 | ||
| Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study | Q39863525 | ||
| The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients | Q43714093 | ||
| Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis | Q44453472 | ||
| The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis | Q44558171 | ||
| Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? | Q45235877 | ||
| Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis | Q45333297 | ||
| Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. | Q50701881 | ||
| Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial | Q51652663 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| rheumatoid arthritis | Q187255 | ||
| veteran | Q193891 | ||
| coronary artery disease | Q844935 | ||
| hyperlipidemia | Q1079120 | ||
| P304 | page(s) | 341-347 | |
| P577 | publication date | 2015-01-21 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Association of hyperlipidaemia, inflammation and serological status and coronary heart disease among patients with rheumatoid arthritis: data from the National Veterans Health Administration | |
| P478 | volume | 75 |
| Q64123686 | An Observational Study of Cardiovascular Risks Associated with Rheumatoid Arthritis Therapies: A Comparison of Two Analytical Approaches |
| Q89970218 | Association between biologic disease modifying anti-rheumatic drugs and incident hypertension in patients with rheumatoid arthritis: Results from prospective nationwide KOBIO Registry |
| Q55043697 | Association between inflammation and systolic blood pressure in RA compared to patients without RA. |
| Q38837769 | Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster |
| Q64092332 | Cardiac and vascular complications in rheumatoid arthritis |
| Q38937245 | Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study |
| Q92464675 | Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment |
| Q26738461 | Cardiovascular risk assessment in rheumatoid arthritis - controversies and the new approach |
| Q36830958 | Correlation of Paraoxonase Status with Disease Activity Score and Systemic Inflammation in Rheumatoid Arthritic Patients |
| Q99638169 | Ethnic Disparities in Atherosclerotic Cardiovascular Disease Incidence and Prevalence Among Rheumatoid Arthritis Patients in the United States: a Systematic Review |
| Q36155818 | High serum cholesterol predicts rheumatoid arthritis in women, but not in men: a prospective study |
| Q37156561 | Impact of disease activity and treatment of comorbidities on the risk of myocardial infarction in rheumatoid arthritis |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q49721726 | Lipids in RA: Is Less Not Necessarily More? |
| Q41464826 | Prevalence of Asymptomatic Arterial Hypertension and Its Correlation with Inflammatory Activity in Early Rheumatoid Arthritis. |
| Q94584824 | Prognostic values of the SYNTAX score II and the erythrocyte sedimentation rate on long-term clinical outcomes in STEMI patients with multivessel disease: a retrospective cohort study |
| Q58728255 | Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis |
| Q92442225 | Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis |
| Q92771595 | Risk of major adverse cardiovascular events among patients with rheumatoid arthritis after initial CT-based diagnosis and treatment |
| Q58555310 | Screening of Hyperlipidemia among Patients with Rheumatoid Arthritis in the United States |
| Q38797087 | Serious adverse events and the risk of stroke in patients with rheumatoid arthritis: results from the German RABBIT cohort. |
| Q28074148 | What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis? |
Search more.